Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Gci Liberty Inc Cl A (GLIBA)

Gci Liberty Inc Cl A (GLIBA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,382,822
  • Shares Outstanding, K 105,650
  • Annual Sales, $ 739,760 K
  • Annual Income, $ -873,300 K
  • 60-Month Beta 1.36
  • Price/Sales 9.98
  • Price/Cash Flow 204.84
  • Price/Book 1.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.25
  • Number of Estimates 1
  • High Estimate -0.25
  • Low Estimate -0.25
  • Prior Year -0.17
  • Growth Rate Est. (year over year) -47.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.82 +3.04%
on 11/07/19
74.31 -5.96%
on 11/20/19
+1.02 (+1.48%)
since 11/06/19
3-Month
60.44 +15.62%
on 09/27/19
74.31 -5.96%
on 11/20/19
+5.97 (+9.34%)
since 09/06/19
52-Week
38.72 +80.48%
on 12/27/18
74.31 -5.96%
on 11/20/19
+22.66 (+47.99%)
since 12/06/18

Most Recent Stories

More News
GCI Liberty (GLIBA) Reports Q3 Loss, Tops Revenue Estimates

GCI Liberty (GLIBA) delivered earnings and revenue surprises of 0.00% and 5.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

GLIBA : 69.88 (-0.01%)
Will GCI Liberty (GLIBA) Report Negative Earnings Next Week? What You Should Know

GCI Liberty (GLIBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GLIBA : 69.88 (-0.01%)
Analysts Estimate GCI Liberty (GLIBA) to Report a Decline in Earnings: What to Look Out for

GCI Liberty (GLIBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GLIBA : 69.88 (-0.01%)
Positive Wireless National Stock Outlook Exudes Confidence

Positive Wireless National Stock Outlook Exudes Confidence

VZ : 61.19 (+0.61%)
USM : 34.92 (+2.25%)
GLIBA : 69.88 (-0.01%)
CTL : 14.16 (+0.14%)
GCI Liberty (GLIBA) Reports Q1 Loss, Lags Revenue Estimates

GCI Liberty (GLIBA) delivered earnings and revenue surprises of -286.21% and -1.03%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

GLIBA : 69.88 (-0.01%)
Zacks.com featured highlights include: Teledyne, Genfit, Shoe Carnival, ZTO and GCI

Zacks.com featured highlights include: Teledyne, Genfit, Shoe Carnival, ZTO and GCI

ZTO : 20.92 (+0.53%)
TDY : 347.29 (+0.60%)
SCVL : 37.63 (+3.21%)
GLIBA : 69.88 (-0.01%)
GNFT : 15.75 (+0.64%)
New Research Coverage Highlights BioMarin Pharmaceutical, EnLink Midstream, GCI Liberty, Vistra Energy, BioTime, and Karyopharm Therapeutics -- Consolidated Revenues, Company Growth, and Expectations for 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN),...

BMRN : 79.92 (-0.20%)
ENLC : 4.46 (-0.22%)
GLIBA : 69.88 (-0.01%)
VST : 24.09 (-1.47%)
BTX : 0.92 (-7.08%)
KPTI : 16.29 (-6.65%)
U.S. Cellular Inks 5G Network Modernization Deal With Nokia

U.S. Cellular Corporation's (USM) strategic deal with Nokia will enable it to tap new customer segments, driving the transition of global enterprises to smart virtual networks.

NOK : 3.48 (unch)
GOGO : 5.66 (-2.41%)
USM : 34.92 (+2.25%)
GLIBA : 69.88 (-0.01%)
Verizon Boosts Network Detection With ProtectWise Buyout

Verizon Communications (VZ) aims to tap ProtectWise's functionalities to improve its capacities and capabilities as it expands 5G footprint.

VZ : 61.19 (+0.61%)
GOGO : 5.66 (-2.41%)
TNAV : 5.33 (+1.72%)
GLIBA : 69.88 (-0.01%)
Factors of Influence in 2019, Key Indicators and Opportunity within EnLink Midstream, Pepsico, Arista Networks, Maiden, GCI Liberty, and Akari Therapeutics -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of EnLink Midstream, LLC (NYSE:ENLC),...

ENLC : 4.46 (-0.22%)
PEP : 137.36 (+0.75%)
ANET : 190.21 (-0.75%)
MHLD : 0.65 (-3.26%)
GLIBA : 69.88 (-0.01%)
AKTX : 1.98 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade GLIBA with:

Business Summary

GCI Liberty, Inc. provides telecommunication services. The Company offers broadband, television, tariff information, bills payment, connection and installation and other related services. GCI Liberty, Inc. is headquartered in Alaska, North America.

See More

Key Turning Points

2nd Resistance Point 70.87
1st Resistance Point 70.38
Last Price 69.88
1st Support Level 69.53
2nd Support Level 69.17

See More

52-Week High 74.31
Last Price 69.88
Fibonacci 61.8% 60.71
Fibonacci 50% 56.51
Fibonacci 38.2% 52.32
52-Week Low 38.72

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar